1,626
Views
12
CrossRef citations to date
0
Altmetric
Review Article

The octanoylated energy regulating hormone ghrelin: An expanded view of ghrelin’s biological interactions and avenues for controlling ghrelin signaling

, & ORCID Icon
Pages 111-124 | Received 09 Aug 2017, Accepted 02 Oct 2017, Published online: 16 Nov 2017

References

  • Allas S, Delale T, Ngo N, Julien M, Sahakian P, Ritter J, et al. 2016. Safety, tolerability, pharmacokinetics and pharmacodynamics of azp-531, a first-in-class analogue of unacylated ghrelin, in healthy and overweight/obese subjects and subjects with type 2 diabetes. Diabetes Obes Metab 18:868–874.
  • Anderwald C, Brabant G, Bernroider E, Horn R, Brehm A, Waldhausl W, Roden M. 2003. Insulin-dependent modulation of plasma ghrelin and leptin concentrations is less pronounced in type 2 diabetic patients. Diabetes 52:1792–1798.
  • Andrews ZB, Erion D, Beiler R, Liu ZW, Abizaid A, Zigman J, et al. 2009. Ghrelin promotes and protects nigrostriatal dopamine function via a ucp2-dependent mitochondrial mechanism. J Neurosci 29:14057–14065.
  • Avau B, Carbone F, Tack J, Depoortere I. 2013. Ghrelin signaling in the gut, its physiological properties, and therapeutic potential. Neurogastroenterol Motil 25:720–732.
  • Barazzoni R, Zanetti M, Ferreira C, Vinci P, Pirulli A, Mucci M, et al. 2007. Relationships between desacylated and acylated ghrelin and insulin sensitivity in the metabolic syndrome. J Clin Endocrinol Metab 92:3935–3940.
  • Barim AO, Aydin S, Colak R, Dag E, Deniz O, Sahin I. 2009. Ghrelin, paraoxonase and arylesterase levels in depressive patients before and after citalopram treatment. Clin Biochem 42:1076–1081.
  • Barnett BP, Hwang Y, Taylor MS, Kirchner H, Pfluger PT, Bernard V, et al. 2010. Glucose and weight control in mice with a designed ghrelin O-acyltransferase inhibitor. Science 330:1689–1692.
  • Beaumont NJ, Skinner VO, Tan TM, Ramesh BS, Byrne DJ, Maccoll GS, et al. 2003. Ghrelin can bind to a species of high density lipoprotein associated with paraoxonase. J Biol Chem 278:8877–8880.
  • Bednarek MA, Feighner SD, Pong SS, Mckee KK, Hreniuk DL, Silva MV, et al. 2000. Structure-function studies on the new growth hormone-releasing peptide, ghrelin: Minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a. J Med Chem 43:4370–4376.
  • Benso A, St-Pierre DH, Prodam F, Gramaglia E, Granata R, Van Der Lely AJ, et al. 2012. Metabolic effects of overnight continuous infusion of unacylated ghrelin in humans. Eur J Endocrinol 166:911–916.
  • Brimijoin S, Chen VP, Pang YP, Geng L, Gao Y. 2016. Physiological roles for butyrylcholinesterase: a BCHE-Ghrelin axis. Chem Biol Interact 259:271–275.
  • Broglio F, Arvat E, Benso A, Gottero C, Muccioli G, Papotti M, et al. 2001. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab 86:5083–5086.
  • Broglio F, Arvat E, Benso A, Papotti M, Muccioli G, Deghenghi R, Ghigo E. 2002. Ghrelin: endocrine and non-endocrine actions. J Pediatr Endocrinol Metab 15(Suppl 5):1219–1227.
  • Broglio F, Gottero C, Prodam F, Gauna C, Muccioli G, Papotti M, et al. 2004. Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. J Clin Endocrinol Metab 89:3062–3065.
  • Buglino JA, Resh MD. 2012. Palmitoylation of hedgehog proteins. Vitam Horm 88:229–252.
  • Callaghan B, Furness JB. 2014. Novel and conventional receptors for ghrelin, desacyl-ghrelin, and pharmacologically related compounds. Pharmacol Rev 66:984–1001.
  • Camer D, Yu Y, Szabo A, Dinh CH, Wang H, Cheng L, Huang XF. 2015. Bardoxolone methyl prevents insulin resistance and the development of hepatic steatosis in mice fed a high-fat diet. Mol Cell Endocrinol 412:36–43.
  • Cameron KO, Bhattacharya SK, Loomis AK. 2014. Small molecule ghrelin receptor inverse agonists and antagonists. J Med Chem 57:8671–8691.
  • Camina JP, Carreira MC, El Messari S, Llorens-Cortes C, Smith RG, Casanueva FF. 2004. Desensitization and endocytosis mechanisms of ghrelin-activated growth hormone secretagogue receptor 1a. Endocrinology 145:930–940.
  • Cederberg H, Koivisto VM, Jokelainen J, Surcel HM, Keinanen-Kiukaanniemi S, Rajala U. 2012. Unacylated ghrelin is associated with changes in insulin sensitivity and lipid profile during an exercise intervention. Clin Endocrinol 76:39–45.
  • Celi F, Bini V, Papi F, Santilli E, Ferretti A, Mencacci M, et al. 2005. Circulating acylated and total ghrelin and galanin in children with insulin-treated type 1 diabetes: relationship to insulin therapy, metabolic control and pubertal development. Clin Endocrinol 63:139–145.
  • Chang SC, Magee AI. 2009. Acyltransferases for secreted signalling proteins (Review). Mol Membr Biol 26:104–113.
  • Chen CY, Fujimiya M, Asakawa A, Chang FY, Cheng JT, Lee SD, Inui A. 2009. At the cutting edge: Ghrelin gene products in food intake and gut motility. Neuroendocrinology 89:9–17.
  • Chen VP, Gao Y, Geng L, Brimijoin S. 2017. Butyrylcholinesterase regulates central ghrelin signaling and has an impact on food intake and glucose homeostasis. Int J Obes. 41:1413–1419.
  • Chen VP, Gao Y, Geng L, Parks RJ, Pang YP, Brimijoin S. 2015. Plasma butyrylcholinesterase regulates ghrelin to control aggression. Proc Natl Acad Sci USA 112:2251–2256.
  • Chollet C, Meyer K, Beck-Sickinger AG. 2009. Ghrelin – a novel generation of anti-obesity drug: design, pharmacomodulation and biological activity of ghrelin analogues. J Pept Sci 15:711–730.
  • Chuang JC, Zigman JM. 2010. Ghrelin’s roles in stress, mood, and anxiety regulation. Int J Pept 2010:460549.
  • Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, Purnell JQ. 2002. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 346:1623–1630.
  • Dantas VG, Furtado-Alle L, Souza RL, Chautard-Freire-Maia EA. 2011. Obesity and variants of the ghrl (ghrelin) and bche (butyrylcholinesterase) genes. Genet Mol Biol 34:205–207.
  • Darling JE, Prybolsky EP, Sieburg M, Hougland JL. 2013. A fluorescent peptide substrate facilitates investigation of ghrelin recognition and acylation by ghrelin O-acyltransferase. Anal Biochem 437:68–76.
  • Darling JE, Zhao F, Loftus RJ, Patton LM, Gibbs RA, Hougland JL. 2015. Structure-activity analysis of human ghrelin O-acyltransferase reveals chemical determinants of ghrelin selectivity and acyl group recognition. Biochemistry 54:1100–1110.
  • Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, Suganuma T, et al. 2000. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 141:4255–4261.
  • Date Y, Nakazato M, Hashiguchi S, Dezaki K, Mondal MS, Hosoda H, et al. 2002. Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion. Diabetes 51:124–129.
  • De Vriese C, Gregoire F, Lema-Kisoka R, Waelbroeck M, Robberecht P, Delporte C. 2004. Ghrelin degradation by serum and tissue homogenates: identification of the cleavage sites. Endocrinology 145:4997–5005.
  • De Vriese C, Hacquebard M, Gregoire F, Carpentier Y, Delporte C. 2007. Ghrelin interacts with human plasma lipoproteins. Endocrinology 148:2355–2362.
  • De Zeeuw D, Akizawa T, Audhya P, Bakris GL, Chin M, Christ-Schmidt H, et al. 2013. Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N Engl J Med 369:2492–2503.
  • Delhanty PJ, Huisman M, Baldeon-Rojas LY, Van Den Berge I, Grefhorst A, Abribat T, et al. 2013. Des-acyl ghrelin analogs prevent high-fat-diet-induced dysregulation of glucose homeostasis. faseb J 27:1690–1700.
  • Delhanty PJ, Huisman M, Julien M, Mouchain K, Brune P, Themmen AP, et al. 2015. The acylated (AG) to unacylated (UAG) ghrelin ratio in esterase inhibitor-treated blood is higher than previously described. Clin Endocrinol 82:142–146.
  • Delhanty PJ, Sun Y, Visser JA, Van Kerkwijk A, Huisman M, Van Ijcken WF, et al. 2010. Unacylated ghrelin rapidly modulates lipogenic and insulin signaling pathway gene expression in metabolically active tissues of GHSR deleted mice. PLoS One 5:e11749.
  • Delhanty PJ, Van Der Lely AJ. 2011. Ghrelin and glucose homeostasis. Peptides 32:2309–2318.
  • Dinh CH, Szabo A, Camer D, Yu Y, Wang H, Huang XF. 2015. Bardoxolone methyl prevents fat deposition and inflammation in the visceral fat of mice fed a high-fat diet. Chem Biol Interact 229:1–8.
  • Doubravska L, Krausova M, Gradl D, Vojtechova M, Tumova L, Lukas J, et al. 2011. Fatty acid modification of wnt1 and wnt3a at serine is prerequisite for lipidation at cysteine and is essential for wnt signalling. Cell Signal 23:837–848.
  • Egido EM, Rodriguez-Gallardo J, Silvestre RA, Marco J. 2002. Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion. Eur J Endocrinol 146:241–244.
  • Erdmann J, Lippl F, Wagenpfeil S, Schusdziarra V. 2005. Differential association of basal and postprandial plasma ghrelin with leptin, insulin, and type 2 diabetes. Diabetes 54:1371–1378.
  • Eubanks LM, Stowe GN, De Lamo Marin S, Mayorov AV, Hixon MS, Janda KD. 2011. Identification of alpha2 macroglobulin as a major serum ghrelin esterase. Angew Chem Int Ed Engl 50:10699–10702.
  • Falken Y, Hellstrom PM, Sanger GJ, Dewit O, Dukes G, Gryback P, et al. 2010. Actions of prolonged ghrelin infusion on gastrointestinal transit and glucose homeostasis in humans. Neurogastroenterol Motil 22:e192–e200.
  • Fetissov SO, Lucas N, Legrand R. 2017. Ghrelin-reactive immunoglobulins in conditions of altered appetite and energy balance. Front Endocrinol 8:10.
  • Francois M, Barde S, Legrand R, Lucas N, Azhar S, El Dhaybi M, et al. 2016a. High-fat diet increases ghrelin-expressing cells in stomach, contributing to obesity. Nutrition 32:709–715.
  • Francois M, Takagi K, Legrand R, Lucas N, Beutheu S, Bole-Feysot C, et al. 2016b. Increased ghrelin but low ghrelin-reactive immunoglobulins in a rat model of methotrexate chemotherapy-induced anorexia. Front Nutr 3:23.
  • Gagnon J, Baggio LL, Drucker DJ, Brubaker PL. 2015. Ghrelin is a novel regulator of glp-1 secretion. Diabetes 64:1513–1521.
  • Gahete MD, Cordoba-Chacon J, Kineman RD, Luque RM, Castano JP. 2011. Role of ghrelin system in neuroprotection and cognitive functions: implications in Alzheimer’s disease. Peptides 32:2225–2228.
  • Galka CS, Hembre EJ, Honigschmidt NA, Martinez-Grau MA, Plaza GR, Rubio A. 2016. Ghrelin o-acyl transferase inhibitors. US Patent Application PCT/US2016/027177.
  • Garner AL, Janda KD. 2010. Cat-elcca: a robust method to monitor the fatty acid acyltransferase activity of ghrelin O-acyltransferase (GOAT). Angew Chem Int Ed Engl 49:9630–9634.
  • Garner AL, Janda KD. 2011. A small molecule antagonist of ghrelin O-acyltransferase (GOAT). Chem Commun (Camb) 47:7512–7514.
  • Gnanapavan S, Kola B, Bustin SA, Morris DG, Mcgee P, Fairclough P, et al. 2002. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-r, in humans. J Clin Endocrinol Metab 87:2988.
  • Goldstein JL, Zhao TJ, Li RL, Sherbet DP, Liang G, Brown MS. 2011. Surviving starvation: essential role of the ghrelin-growth hormone axis. Cold Spring Harb Symp Quant Biol 76:121–127.
  • Gutierrez JA, Solenberg PJ, Perkins DR, Willency JA, Knierman MD, Jin Z, et al. 2008. Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci USA 105:6320–6325.
  • Harran PG, Brown MS, Goldstein JL, Yang J, Zhao TJ. 2012. Small molecule inhibitors of ghrelin O-acyltransferase. US Patent 8329745.
  • Heppner KM, Piechowski CL, Muller A, Ottaway N, Sisley S, Smiley DL, et al. 2014. Both acyl and des-acyl ghrelin regulate adiposity and glucose metabolism via central nervous system ghrelin receptors. Diabetes 63:122–131.
  • Heppner KM, Muller TD, Tong J, Tschop MH. 2012. Ghrelin in the control of energy, lipid, and glucose metabolism. Meth Enzymol 514:249–260.
  • Hofmann K. 2000. A superfamily of membrane-bound O-acyltransferases with implications for wnt signaling. Trends Biochem Sci 25:111–112.
  • Holmes E, Davies I, Lowe G, Ranganath LR. 2009. Circulating ghrelin exists in both lipoprotein bound and free forms. Ann Clin Biochem 46:514–516.
  • Holub JM, Kirshenbaum K. 2010. Tricks with clicks: modification of peptidomimetic oligomers via copper-catalyzed azide-alkyne [3 + 2] cycloaddition. Chem Soc Rev 39:1325–1337.
  • Hopkins AL, Nelson TA, Guschina IA, Parsons LC, Lewis CL, Brown RC, et al. 2017. Unacylated ghrelin promotes adipogenesis in rodent bone marrow via ghrelin O-acyltransferase and ghs-r1a activity: evidence for target cell-induced acylation. Sci Rep 7:45541.
  • Hosoda H, Kojima M, Matsuo H, Kangawa K. 2000. Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun 279:909–913.
  • Hosoda H, Kojima M, Mizushima T, Shimizu S, Kangawa K. 2003. Structural divergence of human ghrelin. Identification of multiple ghrelin-derived molecules produced by post-translational processing. J Biol Chem 278:64–70.
  • Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, et al. 1996. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273:974–977.
  • Julien M, Kay RG, Delhanty PJ, Allas S, Granata R, Barton C, et al. 2012. In vitro and in vivo stability and pharmacokinetic profile of unacylated ghrelin (UAG) analogues. Eur J Pharm Sci 47:625–635.
  • Kaiya H, Koizumi Y, Konno N, Yamamoto K, Uchiyama M, Kangawa K, Miyazato M. 2011. Ghrelin receptor in two species of anuran amphibian, bullfrog (Rana catesbeiana), and Japanese tree frog (Hyla japonica). Front Endocrinol 2:31.
  • Kaiya H, Kojima M, Hosoda H, Koda A, Yamamoto K, Kitajima Y, et al. 2001. Bullfrog ghrelin is modified by n-Octanoic acid at its third threonine residue. J Biol Chem 276:40441–40448.
  • Kaiya H, Sakata I, Yamamoto K, Koda A, Sakai T, Kangawa K, Kikuyama S. 2006. Identification of immunoreactive plasma and stomach ghrelin, and expression of stomach ghrelin mRNA in the bullfrog, Rana catesbeiana. Gen Comp Endocrinol 148:236–244.
  • Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H, Wakabayashi I. 2001. Chronic central infusion of ghrelin increases hypothalamic neuropeptide y and agouti-related protein mRNA levels and body weight in rats. Diabetes 50:2438–2443.
  • Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. 1999. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656–660.
  • Konitsiotis AD, Jovanovic B, Ciepla P, Spitaler M, Lanyon-Hogg T, Tate EW, Magee AI. 2015. Topological analysis of hedgehog acyltransferase, a multipalmitoylated transmembrane protein. J Biol Chem 290:3293–3307.
  • Korbonits M, Bustin SA, Kojima M, Jordan S, Adams EF, Lowe DG, et al. 2001. The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors. J Clin Endocrinol Metab 86:881–887.
  • Kurt E, Guler O, Serteser M, Cansel N, Ozbulut O, Altinbas K, et al. 2007. The effects of electroconvulsive therapy on ghrelin, leptin and cholesterol levels in patients with mood disorders. Neurosci Lett 426:49–53.
  • Kweh FA, Miller JL, Sulsona CR, Wasserfall C, Atkinson M, Shuster JJ, et al. 2015. Hyperghrelinemia in Prader-Willi syndrome begins in early infancy long before the onset of hyperphagia. Am J Med Genet A 167A:69–79.
  • Lau OD, Kundu TK, Soccio RE, Ait-Si-Ali S, Khalil EM, Vassilev A, et al. 2000. Hats off: Selective synthetic inhibitors of the histone acetyltransferases p300 and PCAF. Mol Cell 5:589–595.
  • Lear PV, Iglesias MJ, Feijoo-Bandin S, Rodriguez-Penas D, Mosquera-Leal A, Garcia-Rua V, et al. 2010. Des-acyl ghrelin has specific binding sites and different metabolic effects from ghrelin in cardiomyocytes. Endocrinology 151:3286–3298.
  • Li B, Duysen EG, Lockridge O. 2008. The butyrylcholinesterase knockout mouse is obese on a high-fat diet. Chem Biol Interact 175:88–91.
  • Li RL, Sherbet DP, Elsbernd BL, Goldstein JL, Brown MS, Zhao TJ. 2012. Profound hypoglycemia in starved, ghrelin-deficient mice is caused by decreased gluconeogenesis and reversed by lactate or fatty acids. J Biol Chem 287:17942–17950.
  • Liby KT, Sporn MB. 2012. Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease. Pharmacol Rev 64:972–1003.
  • Lutter M, Sakata I, Osborne-Lawrence S, Rovinsky SA, Anderson JG, Jung S, et al. 2008. The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress. Nat Neurosci 11:752–753.
  • Mager U, Lindi V, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, et al; Finnish Diabetes Prevention Study Group. 2006. Association of the leu72met polymorphism of the ghrelin gene with the risk of type 2 diabetes in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention study. Diabet Med 23:685–689.
  • Manoharan I, Boopathy R, Darvesh S, Lockridge O. 2007. A medical health report on individuals with silent butyrylcholinesterase in the Vysya community of India. Clin Chim Acta 378:128–135.
  • Manoharan I, Wieseler S, Layer PG, Lockridge O, Boopathy R. 2006. Naturally occurring mutation leu307pro of human butyrylcholinesterase in the Vysya community of India. Pharmacogenet Genom 16:461–468.
  • Martinez-Grau MA. 2014. Substituted piperidyl-ethyl-pyrimidine as ghrelin O-acyltransferase inhibitor. US Patent Application PCT/US2014/064202.
  • Matevossian A, Resh MD. 2015. Membrane topology of hedgehog acyltransferase. J Biol Chem 290:2235–2243.
  • McGovern-Gooch KR, Mahajani NS, Garagozzo A, Schramm AJ, Hannah LG, Sieburg MA, et al. 2017. Synthetic triterpenoid inhibition of human ghrelin O-acyltransferase: the involvement of a functionally required cysteine provides mechanistic insight into ghrelin acylation. Biochemistry 56:919–931.
  • McGovern-Gooch KR, Rodrigues T, Darling JE, Sieburg MA, Abizaid A, Hougland JL. 2016. Ghrelin octanoylation is completely stabilized in biological samples by alkyl fluorophosphonates. Endocrinology 157:4330–4338.
  • McGovern KR, Darling JE, Hougland JL. 2016. Progress in small molecule and biologic therapeutics targeting ghrelin signaling. Mini Rev Med Chem 16:465–480.
  • Mizutani M, Atsuchi K, Asakawa A, Matsuda N, Fujimura M, Inui A, et al. 2009. Localization of acyl ghrelin- and des-Acyl ghrelin-immunoreactive cells in the rat stomach and their responses to intragastric ph. Am J Physiol Gastrointest Liver Physiol 297:G974–G980.
  • Moon M, Kim HG, Hwang L, Seo JH, Kim S, Hwang S, et al. 2009. Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease by blocking microglial activation. Neurotox Res 15:332–347.
  • Muller TD, Nogueiras R, Andermann ML, Andrews ZB, Anker SD, Argente J, et al. 2015. Ghrelin. Mol Metab 4:437–460.
  • Murray CD, Martin NM, Patterson M, Taylor SA, Ghatei MA, Kamm MA, et al. 2005. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. Gut 54:1693–1698.
  • Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S. 2001. A role for ghrelin in the central regulation of feeding. Nature 409:194–198.
  • Nishi Y, Hiejima H, Hosoda H, Kaiya H, Mori K, Fukue Y, et al. 2005. Ingested medium-chain fatty acids are directly utilized for the acyl modification of ghrelin. Endocrinology 146:2255–2264.
  • Ohgusu H, Shirouzu K, Nakamura Y, Nakashima Y, Ida T, Sato T, Kojima M. 2009. Ghrelin O-acyltransferase (GOAT) has a preference for n-Hexanoyl-coa over n-Octanoyl-coa as an acyl donor. Biochem Biophys Res Commun 386:153–158.
  • Parang K, Till JH, Ablooglu AJ, Kohanski RA, Hubbard SR, Cole PA. 2001. Mechanism-based design of a protein kinase inhibitor. Nat Struct Biol 8:37–41.
  • Peino R, Baldelli R, Rodriguez-Garcia J, Rodriguez-Segade S, Kojima M, Kangawa K, et al. 2000. Ghrelin-induced growth hormone secretion in humans. Eur J Endocrinol 143:R11–R14.
  • Pepinsky RB, Zeng C, Wen D, Rayhorn P, Baker DP, Williams KP, et al. 1998. Identification of a palmitic acid-modified form of human sonic hedgehog. J Biol Chem 273:14037–14045.
  • Poykko SM, Kellokoski E, Horkko S, Kauma H, Kesaniemi YA, Ukkola O. 2003. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 52:2546–2553.
  • Purnell JQ, Weigle DS, Breen P, Cummings DE. 2003. Ghrelin levels correlate with insulin levels, insulin resistance, and high-density lipoprotein cholesterol, but not with gender, menopausal status, or cortisol levels in humans. J Clin Endocrinol Metab 88:5747–5752.
  • Reimer MK, Pacini G, Ahren B. 2003. Dose-dependent inhibition by ghrelin of insulin secretion in the mouse. Endocrinology 144:916–921.
  • Rindi G, Necchi V, Savio A, Torsello A, Zoli M, Locatelli V, et al. 2002. Characterisation of gastric ghrelin cells in man and other mammals: studies in adult and fetal tissues. Histochem Cell Biol 117:511–519.
  • Romero A, Kirchner H, Heppner K, Pfluger PT, Tschop MH, Nogueiras R. 2010. GOAT: the master switch for the ghrelin system? Eur J Endocrinol 163:1–8.
  • Saha PK, Reddy VT, Konopleva M, Andreeff M, Chan L. 2010. Antidiabetic effect and mode of action of the triterpenoid, CDDO-Me, in diet-induced type 2 diabetic mice and Lepr(db/db) mice. Diabetes 59:A372–A372.
  • Satou M, Nishi Y, Yoh J, Hattori Y, Sugimoto H. 2010. Identification and characterization of acyl-protein thioesterase 1/lysophospholipase i as a ghrelin deacylation/lysophospholipid hydrolyzing enzyme in fetal bovine serum and conditioned medium. Endocrinology 151:4765–4775.
  • Schopfer LM, Lockridge O, Brimijoin S. 2015. Pure human butyrylcholinesterase hydrolyzes octanoyl ghrelin to desacyl ghrelin. Gen Comp Endocrinol 224:61–68.
  • Seim I, Jeffery PL, Thomas PB, Walpole CM, Maugham M, Fung JN, et al. 2016. Multi-species sequence comparison reveals conservation of ghrelin gene-derived splice variants encoding a truncated ghrelin peptide. Endocrine 52:609–617.
  • Shiiya T, Nakazato M, Mizuta M, Date Y, Mondal MS, Tanaka M, et al. 2002. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 87:240–244.
  • Shintani M, Ogawa Y, Ebihara K, Aizawa-Abe M, Miyanaga F, Takaya K, et al. 2001. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide y/y1 receptor pathway. Diabetes 50:227–232.
  • Spencer SJ, Emmerzaal TL, Kozicz T, Andrews ZB. 2015. Ghrelin’s role in the hypothalamic-pituitary-adrenal axis stress response: implications for mood disorders. Biol Psychiatry 78:19–27.
  • Steculorum SM, Collden G, Coupe B, Croizier S, Lockie S, Andrews ZB, et al. 2015. Neonatal ghrelin programs development of hypothalamic feeding circuits. J Clin Invest 125:846–858.
  • Stengel A, Tache Y. 2012. Ghrelin: a pleiotropic hormone secreted from endocrine x/a-like cells of the stomach. Front Neurosci 6:24.
  • Stevanovic DM, Grefhorst A, Themmen AP, Popovic V, Holstege J, Haasdijk E, et al. 2014. Unacylated ghrelin suppresses ghrelin-induced neuronal activity in the hypothalamus and brainstem of male rats [corrected]. PLoS One 9:e98180.
  • Tack J, Depoortere I, Bisschops R, Delporte C, Coulie B, Meulemans A, et al. 2006. Influence of ghrelin on interdigestive gastrointestinal motility in humans. Gut 55:327–333.
  • Takada R, Satomi Y, Kurata T, Ueno N, Norioka S, Kondoh H, et al. 2006. Monounsaturated fatty acid modification of WNT protein: its role in WNT secretion. Dev Cell 11:791–801.
  • Takagi K, Legrand R, Asakawa A, Amitani H, Francois M, Tennoune N, et al. 2013. Anti-ghrelin immunoglobulins modulate ghrelin stability and its orexigenic effect in obese mice and humans. Nat Commun 4:2685.
  • Takahashi T, Ida T, Sato T, Nakashima Y, Nakamura Y, Tsuji A, Kojima M. 2009. Production of n-Octanoyl-modified ghrelin in cultured cells requires prohormone processing protease and ghrelin O-acyltransferase, as well as n-Octanoic acid. J Biochem 146:675–682.
  • Takakura N, Banno Y, Terao Y, Ochida A, Morimoto S, Kitamura S, et al. 2013. Aromatic ring compound. US Patent 9238639
  • Takaya K, Ariyasu H, Kanamoto N, Iwakura H, Yoshimoto A, Harada M, et al. 2000. Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab 85:4908–4911.
  • Taylor MS, Dempsey DR, Hwang Y, Chen Z, Chu N, Boeke JD, Cole PA. 2015. Mechanistic analysis of ghrelin-O-acyltransferase using substrate analogs. Bioorg Chem 62:64–73.
  • Taylor MS, Ruch TR, Hsiao PY, Hwang Y, Zhang P, Dai L, et al. 2013. Architectural organization of the metabolic regulatory enzyme ghrelin O-acyltransferase. J Biol Chem 288:32211–32228.
  • Teubner BJ, Garretson JT, Hwang Y, Cole PA, Bartness TJ. 2013. Inhibition of ghrelin O-acyltransferase attenuates food deprivation-induced increases in ingestive behavior. Horm Behav 63:667–673.
  • Teuffel P, Wang L, Prinz P, Goebel-Stengel M, Scharner S, Kobelt P, et al. 2015. Treatment with the ghrelin-O-acyltransferase (GOAT) inhibitor GO-Coa-Tat reduces food intake by reducing meal frequency in rats. J Physiol Pharmacol 66:493–503.
  • Togliatto G, Trombetta A, Dentelli P, Gallo S, Rosso A, Cotogni P, et al. 2015. Unacylated ghrelin induces oxidative stress resistance in a glucose intolerance and peripheral artery disease mouse model by restoring endothelial cell mir-126 expression. Diabetes 64:1370–1382.
  • Tong J, Prigeon RL, Davis HW, Bidlingmaier M, Kahn SE, Cummings DE, et al. 2010. Ghrelin suppresses glucose-stimulated insulin secretion and deteriorates glucose tolerance in healthy humans. Diabetes 59:2145–2151.
  • Tschop M, Smiley DL, Heiman ML. 2000. Ghrelin induces adiposity in rodents. Nature 407:908–913.
  • Van Der Ploeg L, Laken H, Sharma S, Datta R, Halem H, Dong J, et al. 2014. Preclinical gastrointestinal prokinetic efficacy and endocrine effects of the ghrelin mimetic RM-131. Life Sci 109:20–29.
  • Wellman MK, Patterson ZR, Mackay H, Darling JE, Mani BK, Zigman JM, et al. 2015. Novel regulator of acylated ghrelin, cf801, reduces weight gain, rebound feeding after a fast, and adiposity in mice. Front Endocrinol 6:144.
  • Willert K, Brown JD, Danenberg E, Duncan AW, Weissman IL, Reya T, et al. 2003. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423:448–452.
  • Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, et al. 2001. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86:5992
  • Yada T, Damdindorj B, Rita RS, Kurashina T, Ando A, Taguchi M, et al. 2014. Ghrelin signalling in beta-cells regulates insulin secretion and blood glucose. Diabetes Obes Metab 16 Suppl 1:111–117.
  • Yang J, Brown MS, Liang G, Grishin NV, Goldstein JL. 2008a. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 132:387–396.
  • Yang J, Zhao TJ, Goldstein JL, Brown MS. 2008b. Inhibition of ghrelin O-acyltransferase (GOAT) by octanoylated pentapeptides. Proc Natl Acad Sci USA 105:10750–10755.
  • Yao J, Yuan Y, Zheng F, Zhan CG. 2016. Unexpected reaction pathway for butyrylcholinesterase-catalyzed inactivation of “hunger hormone” ghrelin. Sci Rep 6:22322.
  • Yoh J, Nishi Y, Hosoda H, Tajiri Y, Yamada K, Yanase T, et al. 2011. Plasma levels of n-decanoyl ghrelin, another acyl- and active-form of ghrelin, in human subjects and the effect of glucose- or meal-ingestion on its dynamics. Regul Pept 167:140–148.
  • Zhao F, Darling JE, Gibbs RA, Hougland JL. 2015. A new class of ghrelin O-acyltransferase inhibitors incorporating triazole-linked lipid mimetic groups. Bioorg Med Chem Lett 25:2800–2803.
  • Zhao TJ, Sakata I, Li RL, Liang G, Richardson JA, Brown MS, et al. 2010. Ghrelin secretion stimulated by {beta}1-adrenergic receptors in cultured ghrelinoma cells and in fasted mice. Proc Natl Acad Sci USA 107:15868–15873.
  • Zhou A, Webb G, Zhu X, Steiner DF. 1999. Proteolytic processing in the secretory pathway. J Biol Chem 274:20745–20748.
  • Zhu X, Cao Y, Voogd K, Steiner DF. 2006. On the processing of proghrelin to ghrelin. J Biol Chem 281:38867–38870.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.